This study provided the first evidence of a relationship of WRN promoter methylation with cervical cancer, with aberrant methylation of WRN detected in 33.3% of specimens of cervical cancer and in two cervical cancer-derived cell lines. Here, WRN is linked to cervical carcinoma.